Catalyst Wire Dossier Catalyst Wire Dossier

BAXDELA

delafloxacin meglumine · Melinta Therapeutics, LLC
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for BAXDELA, covering 2017-06-19 to 2023-12-01. Get the full timeline:

Most recent: FDA Approved: BAXDELA — Supplemental Application (Melinta Therapeutics, LLC)

See pricing